Prosecution Insights
Last updated: August 18, 2026

Examiner: STRIEGEL, THEODORE CHARLES

Tech Center 1600 • Art Units: 1671 1685

This examiner grants 20% of resolved cases

Performance Statistics

20.0%
Allow Rate
-40.0% vs TC avg
75
Total Applications
+20.7%
Interview Lift
1652
Avg Prosecution Days
Based on 60 resolved cases, 2023–2026

Rejection Statute Breakdown

29.2%
§101 Eligibility
4.7%
§102 Novelty
32.0%
§103 Obviousness
23.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18362382 MEDICAL DEVICE SYSTEM FOR CLASSIFICATION AND PREDICTION OF MEDICAL EVENTS USING TIME-BETWEEN-EVENT VALUES Non-Final OA Boston Scientific Scimed, Inc.
16963093 BIOMARKERS AND CLASSIFICATION ALGORITHMS FOR CHRONIC KIDNEY DISEASE IN CATS Final Rejection MARS, INCORPORATED
17091484 Accurate And Robust Information-Deconvolution From Bulk Tissue Transcriptomes Final Rejection Regeneron Pharmaceuticals, Inc.
18250140 SYSTEMS AND METHODS FOR QUANTIFYING PATIENT IMPROVEMENT THROUGH ARTIFICIAL INTELLIGENCE Non-Final OA Northwestern University
17590095 INTERMEDIATE RECURRENT PARENTS, AN ACCELERATED AND EFFICIENT MULTI-LAYER TRAIT DELIVERY SYSTEM Final Rejection Monsanto Technology LLC
17560274 TECHNOLOGIES FOR NUCLEOTIDE SEQUENCE SCREENING Final Rejection Battelle Memorial Institute
19093034 VARIANT CLASSIFIER BASED ON DEEP NEURAL NETWORKS Non-Final OA Illumina, Inc.
18297470 IDENTIFYING TREATMENT RESPONSE SIGNATURES Non-Final OA Rutgers, The State University of New Jersey
18255852 Systems and Methods for Dynamic Raman Profiling of Biological Diseases and Disorders Non-Final OA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month